非药物干预对中年妇女更年期症状的影响:系统性审查和元分析
1College of Nursing, Sahmyook University, 815 Hwarang-ro, Nowon-gu, Seoul 01795, Republic of Korea.
Healthcare (Basel, Switzerland)
|December 30, 2025
概括
非药物干预有效地管理中年妇女的绝经症状,如抑郁和焦虑. 营养,草药,心理和以运动为基础的方法为激素治疗提供了更安全的替代方案,改善了整体福祉.
科学领域:
- 妇女健康 妇女健康
- 综合医学是一个整体的医学.
- 基于证据的实践.
背景情况:
- 更年期通常会导致中年妇女的身体和心理症状,包括抑郁,焦虑,睡眠问题和血管运动症状.
- 人们越来越担心荷尔蒙疗法的副作用,因此人们对更安全,非药物治疗的症状管理策略越来越感兴趣.
- 非药物干预越来越被认为是管理更年期症状的可行的替代方案.
研究的目的:
- 系统地审查和元分析非药物干预措施的有效性,以缓解中年妇女更年期症状.
- 为了比较各种非药理学方法的有效性,包括营养,草药,心理和基于运动的疗法.
- 提供基于证据的建议,以非药物手段管理更年期症状.
主要方法:
- 来自八个数据库的32项随机对照试验的系统审查和元分析.
- 干预措施被分为营养/草药,心理,基于炼和补充疗法.
- 柯克兰偏差风险工具和随机效应模型用于数据分析.
主要成果:
- 抑郁症 (SMD = -1.10),焦虑症 (-0.82),睡眠障碍 (-0.90),更年期整体症状 (-1.18) 和热 (-0.34) 的显著减少.
- 营养和草药干预表明了最一致的积极影响.
- 心理和以运动为基础的干预措施对睡眠和情绪健康特别有效.
结论:
- 非药物干预在改善更年期症状和生活质量方面是有效的.
- 量身定制的,多方面的方法,特别是护士领导的社区计划,产生了最大的影响.
- 标准化协议,文化敏感性和持续评估对于持续的积极结果至关重要.
更多相关视频
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
982
05:36Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
Published on: October 4, 2024
1.1K
相关概念视频
Menopause
3.5K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.5K
Hormonal Regulation of the Menstrual Cycle
1.4K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.4K
Pharmacodynamics in Geriatric Patients: Effects of Age
174
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
174
